Opinion|Videos|September 30, 2024
Dravet Syndrome Diagnosis
Author(s)M. Scott Perry, MD
Scott Perry, MD, discusses how Dravet syndrome is diagnosed through a combination of clinical observation, genetic testing, and phenotypic evaluation, emphasizing the challenges and importance of early diagnosis to improve patient outcomes.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How is Dravet syndrome diagnosed?
- Discuss how patients are screened for Dravet syndrome.
- What is the role of genetic testing in Dravet syndrome?
- Discuss diagnosing patients based on characteristics/phenotyping.
- What are the challenges associated with Dravet syndrome diagnosis?
- Please discuss the need for early diagnosis.
Advertisement
Related to this article
An epileptologist at Cleveland Clinic discussed findings from a recently published study of lifestyle interventions in epilepsy and why these approaches should complement rather than replace antiseizure medications.
Pediatric epilepsy care goes beyond seizures, addressing mental health, learning needs, coordinated referrals, equitable access, and smoother transition to adult services.
Here's some of what is coming soon to NeurologyLive® this week.
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with M. Scott Perry, MD. [LISTEN TIME: 15 minutes]
The 36-month CORE-VNS study findings showed sustained seizure reduction, improved quality of life, and reduced seizure-related hospitalizations among people with drug-resistant epilepsy receiving vagus nerve stimulation therapy.
Here's some of what is coming soon to NeurologyLive® this week.
Servier reported that sevasemten did not meet its primary or secondary endpoints in the pivotal GRAND CANYON trial for Becker muscular dystrophy.
QurAlis reported interim ANQUR trial results showing target engagement, a biomarker signal, and a trend toward slower functional decline with QRL-201 in ALS.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Final Results Reported for EPISOD1 Trial of SOD1-ALS Gene Therapy AMT-162
2
Recapping the 2026 STARS Conference and the Push for Interdisciplinary Stuttering Care: Gerald Maguire, MD
3
FDA Grants Priority Review to Huntington Disease Gene Therapy BLA
4
Examining Sustained Disability Signals With Vidofludimus Calcium in Progressive MS: Robert J. Fox, MD
5